The Effect of 5-Alpha Reductase Inhibitor on Th1, Th2, and Th17 Cell-Related Inflammatory Response in Benign Prostatic Hyperplasia

    April 2023 in “ World Journal of Urology
    Yifan Chu, Mengdong Zhang, Yun Cui … Jianwen Wang
    Studysummary In this study, researchers found that using a 5-α reductase inhibitor may reduce inflammation-related cytokines associated with T-helper cell 1 and T-helper cell 2 in prostate tissues after surgery, but it did not affect those related to Th17 cells.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on dx.doi.org →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Dihydrotestosterone And The Prostate: The Scientific Rationale For 5α-Reductase Inhibitors In The Treatment Of Benign Prostatic Hyperplasia ˜The œJournal of urology/˜The œjournal of urology · 2004